Europe
The new Planmeca Compact™ i5 dental unit has been built around five central themes – design, wellbeing, cleanliness, intelligence, and evolution. All of these principles are carried through in every detail of the dental unit, resulting in a perfect combination of functionality, durability, comfort, safety, and aesthetics.
WuXi Biologics, a Shanghai, China-based contract research organization focused on biologics, announced it was expanding its existing collaboration and licensing deals with UK-based Oxford BioTherapeutics (OBT).
NOXXON Pharma N.V. announced today the details of its participation at the ESMO Immuno-Oncology Congress on December 13-16, 2018 at the Palexpo Exhibition Center, 30 Route François-Peyrot, 1218 Le Grand-Saconnex, in Geneva, Switzerland.
Researchers published an article in the journal Nature Ecology & Evolution that described preliminary findings of gene variants in George associated with a strong immune system, efficient DNA repair and cancer resistance.
The Best Biotech Entrepreneur Award® goes to Gilles Avenard, CEO of Acticor Biotech
MorphoSys AG announced today that according to the title of a presentation to be held next Wednesday afternoon CET (December 12, 2018) at the upcoming Inflammatory Skin Disease Summit (ISDS) conference in Vienna, Austria, guselkumab [Tremfya(R)] demonstrates superior long-term responses to secukinumab [Cosentyx(R)] at Week 48 in the treatment of moderate to severe psoriasis, as results from the ECLIPSE trial.
The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year.
The U.S. Food and Drug Administration (FDA) has issued an approval letter for the new features and intended uses of the Planmed Verity® CBCT scanner. Planmed is very pleased to bring these exciting improvements to the U.S. market.
Pharming Group N.V. today acknowledged presentation of the results from an investigator-initiated comparative study of therapies in acute attacks of hereditary angioedema (“HAE”).
Biotech and pharma companies strengthen their leadership teams with these appointments. Who made power moves in the industry this past week?
PRESS RELEASES